What is NextKidney?
NextKidney is dedicated to the development and global commercialization of the NeoKidney home hemodialysis device, a significant advancement in patient-centric renal care. The company's core mission revolves around enhancing the quality of life for individuals undergoing hemodialysis by providing a safe, user-friendly, and accessible solution. Leveraging innovative technologies, NextKidney aims to make home hemodialysis a viable and widespread option worldwide, shifting the paradigm of kidney disease management.
How much funding has NextKidney raised?
NextKidney has raised a total of $8.4M across 1 funding round:
Series B
$8.4M
Series B (2023): $8.4M, investors not publicly disclosed
What's next for NextKidney?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for NextKidney. This capital infusion is expected to accelerate the company's efforts in scaling production, expanding its market reach, and further refining its NeoKidney device. The focus on home hemodialysis positions NextKidney to capitalize on the growing trend towards decentralized healthcare and patient empowerment, potentially disrupting traditional dialysis center models and establishing a new standard of care.
See full NextKidney company page
